Ensysce Biosciences Inc (ENSC)
0.565
0.00 (0.00%)
USD |
NASDAQ |
May 03, 16:00
0.565
0.00 (0.00%)
After-Hours: 20:00
Ensysce Biosciences Max Drawdown (5Y): 99.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 99.99% |
| March 31, 2024 | 99.99% |
| February 29, 2024 | 99.99% |
| January 31, 2024 | 99.99% |
| December 31, 2023 | 99.99% |
| November 30, 2023 | 99.99% |
| October 31, 2023 | 99.98% |
| September 30, 2023 | 99.98% |
| August 31, 2023 | 99.97% |
| July 31, 2023 | 99.97% |
| June 30, 2023 | 99.97% |
| May 31, 2023 | 99.96% |
| April 30, 2023 | 99.94% |
| March 31, 2023 | 99.92% |
| February 28, 2023 | 99.90% |
| January 31, 2023 | 99.87% |
| December 31, 2022 | 99.87% |
| November 30, 2022 | 99.60% |
| October 31, 2022 | 99.33% |
| September 30, 2022 | 99.10% |
| August 31, 2022 | 98.32% |
| July 31, 2022 | 98.25% |
| June 30, 2022 | 98.25% |
| May 31, 2022 | 97.98% |
| April 30, 2022 | 96.00% |
| Date | Value |
|---|---|
| March 31, 2022 | 96.00% |
| February 28, 2022 | 95.62% |
| January 31, 2022 | 94.79% |
| December 31, 2021 | 94.79% |
| November 30, 2021 | 94.21% |
| October 31, 2021 | 90.91% |
| September 30, 2021 | 87.91% |
| August 31, 2021 | 87.91% |
| July 31, 2021 | 76.82% |
| June 30, 2021 | 54.11% |
| May 31, 2021 | 52.02% |
| April 30, 2021 | 52.02% |
| March 31, 2021 | 52.02% |
| February 28, 2021 | 45.39% |
| January 31, 2021 | 19.69% |
| December 31, 2020 | 19.69% |
| November 30, 2020 | 19.69% |
| October 31, 2020 | 19.30% |
| September 30, 2020 | 19.30% |
| August 31, 2020 | 19.30% |
| July 31, 2020 | 19.30% |
| June 30, 2020 | 19.30% |
| May 31, 2020 | 6.64% |
| April 30, 2020 | 5.41% |
| March 31, 2020 | 3.71% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
1.50%
Minimum
May 2019
99.99%
Maximum
Apr 2024
62.45%
Average
92.56%
Median
Max Drawdown (5Y) Benchmarks
| NovaBay Pharmaceuticals Inc | 99.91% |
| Palatin Technologies Inc | 96.46% |
| iBio Inc | 99.97% |
| Theriva Biologics Inc | 99.81% |
| Oragenics Inc | 98.92% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -92.02 |
| Beta (5Y) | 0.8011 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 113.0% |
| Historical Sharpe Ratio (5Y) | -0.7355 |
| Historical Sortino (5Y) | -1.230 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 54.86% |